Continuous venovenous hemodiafiltration in the treatment of septic shock and acute kidney injury in a patient with acute myocardial infarction
https://doi.org/10.15829/1560-4071-2021-4245
About the Authors
K. S. Kozulin
Cardiology Research Institute, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
V. V. Kirilin
Cardiology Research Institute, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
O. O. Panteleev
Cardiology Research Institute, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
E. E. Borodina
Cardiology Research Institute, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
V. V. Ryabov
Cardiology Research Institute, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Tomsk
References
1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-77. doi:10.1007/s00134-017-4683-6.
2. Premuzic V, Basic-Jukic N, Jelakovic B, et al. Differences in CVVH vs. CVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients (2017). J Artif Organs. 2017;20(4):326-34. doi:10.1007/s10047-017-0970-9.
3. Ankawi G, Neri M, Zhang J, et al. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls (2018). Crit Care. 2018;22(1):262. doi:10.1186/s13054-018-2181-z.
Supplementary files
Review
For citations:
Kozulin K.S., Kirilin V.V., Panteleev O.O., Borodina E.E., Ryabov V.V. Continuous venovenous hemodiafiltration in the treatment of septic shock and acute kidney injury in a patient with acute myocardial infarction. Russian Journal of Cardiology. 2021;26(2):4245. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4245
Views:
793
Email this article 